+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Beovu Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • PDF Icon

    Report

  • 175 Pages
  • April 2025
  • Region: Global
  • The Business Research Company
  • ID: 6103629
The beovu market research report is one of a series of new reports that provides beovu market statistics, including beovu industry global market size, regional shares, competitors with a beovu market share, detailed beovu market segments, market trends and opportunities, and any further data you may need to thrive in the beovu industry. This beovu market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The growth in the forecast period can be attributed to rising prevalence of age-related macular degeneration, increasing demand for targeted therapies, potential for longer-lasting treatment options, expanding reimbursement policies, and growing investment in retinal disease research and clinical trials. Major trends in the forecast period include advancements in ophthalmic treatment technologies, development of gene therapy options, integration of AI in treatment planning, shift toward preventive eye care, and advancement of sustained-release drug delivery systems.

The increasing prevalence of retinal diseases is expected to drive the growth of the beovu market in the future. Retinal diseases refer to conditions that affect the retina, the light-sensitive tissue at the back of the eye, including age-related macular degeneration (AMD), diabetic retinopathy, retinal detachment, and macular edema. These conditions often result in vision impairment. The rise in retinal diseases is driven by factors such as aging populations, a growing number of diabetes cases, prolonged screen time, and genetic predispositions, all contributing to higher rates of vision loss and blindness. Beovu treats retinal diseases by inhibiting VEGF, which reduces fluid leakage and swelling in the retina, thereby improving vision, preventing disease progression, and enhancing patient outcomes for conditions such as wet AMD and diabetic macular edema. For example, according to the National Eye Institute, 2.7 million Americans are currently living with glaucoma, a number projected to rise to 4.3 million by 2030. Additionally, 7.7 million Americans are affected by diabetic retinopathy, with this number expected to increase to 11.3 million by 2030. Therefore, the rising incidence of retinal diseases is driving the growth of the beovu market.

The expanding geriatric population is expected to propel the growth of the beovu market in the coming years. The geriatric population includes individuals aged 65 and older, who often experience various health, social, and functional changes due to aging. This population growth is attributed to factors such as advancements in healthcare, better living conditions, improved nutrition, and increased life expectancy. Beovu (brolucizumab) is particularly beneficial for the elderly, as it helps manage age-related macular degeneration (AMD), a common cause of vision impairment in older adults, by reducing retinal fluid accumulation and stabilizing or improving vision. For instance, in July 2024, according to the UK Parliament's House of Commons Library, there were 12.7 million people aged 65 or older in the UK in 2022, representing 19% of the total population. This number is projected to rise to 22.1 million by 2072, accounting for 27% of the population. Consequently, the growing geriatric population is expected to drive growth in the beovu market.

A key trend in the beovu market is the development of innovative therapies, including anti-VEGF injections, to improve treatment outcomes for eye conditions such as wet age-related macular degeneration (AMD) and diabetic macular edema (DME). Anti-VEGF injections target vascular endothelial growth factor (VEGF), a protein responsible for abnormal blood vessel growth in the eye, thus helping to treat conditions such as wet AMD and DME. For example, in March 2022, Novartis AG, a Switzerland-based pharmaceutical company, announced that the European Commission had approved Beovu (brolucizumab) 6 mg for treating visual impairment due to diabetic macular edema (DME), marking its second indication after the 2020 approval for wet age-related macular degeneration (AMD). This approval offers the potential for fewer injections and better treatment outcomes for DME patients.

The key company operating in the beovu market is Novartis AG.

North America was the largest region in the beovu market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in beovu report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the Beovu market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Beovu is a prescription medication used to treat certain eye conditions, including wet age-related macular degeneration (AMD) and diabetic macular edema (DME). This monoclonal antibody works by inhibiting vascular endothelial growth factor (VEGF-A), a protein responsible for the formation of abnormal blood vessels in the eye, which can result in vision problems.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary indications for the beovu market include macular degeneration, diabetic retinopathy, and other related conditions. Macular degeneration is an eye disorder that affects the macula, the central part of the retina, leading to vision loss. It is one of the leading causes of vision impairment in older adults and can progress to a more severe stage, particularly wet age-related macular degeneration (wet AMD), which may require treatments such as Beovu. The available dosage forms include gels, eye solutions, capsules, tablets, eye drops, and ointments. These products are distributed through various channels such as hospital pharmacies, online pharmacies, and retail pharmacies and are used by a wide range of end users, including adults and geriatric patients.

The beovu market consists of sales of beovu vials, pre-filled syringes, multi-dose vials, and single-use injections. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Beovu Market Characteristics
3. Beovu Market Biologic Drug Characteristics
3.1. Molecule Type
3.2. Route Of Administration (ROA)
3.3. Mechanism Of Action (MOA)
3.4. Safety And Efficacy
4. Beovu Market Trends And Strategies5. Beovu Market -Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market
6. Global Beovu Growth Analysis And Strategic Analysis Framework
6.1. Global Beovu PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.2. Analysis Of End Use Industries
6.3. Global Beovu Market Growth Rate Analysis
6.4. Global Beovu Historic Market Size and Growth, 2019 - 2024, Value ($ Million)
6.5. Global Beovu Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)
6.6. Global Beovu Total Addressable Market (TAM)
7. Global Beovu Pricing Analysis & Forecasts
8. Beovu Market Segmentation
8.1. Global Beovu Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Macular Degeneration
  • Diabetic Retinopathy
  • Other Types
8.2. Global Beovu Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Gels
  • Eye Solutions
  • Capsules And Tablets
  • Eye Drops
  • Ointments
8.3. Global Beovu Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
8.4. Global Beovu Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Adult
  • Geriatric
9. Global Beovu Epidemiology Of Clinical Indications
9.1. Drug Side Effects
9.2. Incidence And Prevalence of Clinical Indications
10. Beovu Market Regional And Country Analysis
10.1. Global Beovu Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
10.2. Global Beovu Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11. Asia-Pacific Beovu Market
11.1. Asia-Pacific Beovu Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Beovu Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11.3. Asia-Pacific Beovu Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11.4. Asia-Pacific Beovu Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
12. China Beovu Market
12.1. China Beovu Market Overview
12.2. China Beovu Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
12.3. China Beovu Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
12.4. China Beovu Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
13. India Beovu Market
13.1. India Beovu Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
13.2. India Beovu Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
13.3. India Beovu Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14. Japan Beovu Market
14.1. Japan Beovu Market Overview
14.2. Japan Beovu Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14.3. Japan Beovu Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14.4. Japan Beovu Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15. Australia Beovu Market
15.1. Australia Beovu Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15.2. Australia Beovu Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15.3. Australia Beovu Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16. South Korea Beovu Market
16.1. South Korea Beovu Market Overview
16.2. South Korea Beovu Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16.3. South Korea Beovu Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16.4. South Korea Beovu Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17. Western Europe Beovu Market
17.1. Western Europe Beovu Market Overview
17.2. Western Europe Beovu Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17.3. Western Europe Beovu Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17.4. Western Europe Beovu Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18. UK Beovu Market
18.1. UK Beovu Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18.2. UK Beovu Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18.3. UK Beovu Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19. Germany Beovu Market
19.1. Germany Beovu Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19.2. Germany Beovu Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19.3. Germany Beovu Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20. France Beovu Market
20.1. France Beovu Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20.2. France Beovu Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20.3. France Beovu Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21. Eastern Europe Beovu Market
21.1. Eastern Europe Beovu Market Overview
21.2. Eastern Europe Beovu Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21.3. Eastern Europe Beovu Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21.4. Eastern Europe Beovu Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22. North America Beovu Market
22.1. North America Beovu Market Overview
22.2. North America Beovu Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22.3. North America Beovu Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22.4. North America Beovu Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23. USA Beovu Market
23.1. USA Beovu Market Overview
23.2. USA Beovu Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23.3. USA Beovu Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23.4. USA Beovu Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24. Canada Beovu Market
24.1. Canada Beovu Market Overview
24.2. Canada Beovu Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24.3. Canada Beovu Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24.4. Canada Beovu Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25. South America Beovu Market
25.1. South America Beovu Market Overview
25.2. South America Beovu Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25.3. South America Beovu Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25.4. South America Beovu Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26. Middle East Beovu Market
26.1. Middle East Beovu Market Overview
26.2. Middle East Beovu Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26.3. Middle East Beovu Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26.4. Middle East Beovu Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27. Africa Beovu Market
27.1. Africa Beovu Market Overview
27.2. Africa Beovu Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27.3. Africa Beovu Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27.4. Africa Beovu Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
28. Beovu Market Competitive Landscape And Company Profiles
28.1. Beovu Market Competitive Landscape
28.2. Beovu Market Company Profiles
28.2.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
29. Global Beovu Market Pipeline Analysis
29.1. High Level Clinic Trail Information
30. Global Beovu Market Competitive Benchmarking And Dashboard31. Key Mergers And Acquisitions In The Beovu Market32. Recent Developments In The Beovu Market
33. Beovu Market High Potential Countries, Segments and Strategies
33.1 Beovu Market In 2029 - Countries Offering Most New Opportunities
33.2 Beovu Market In 2029 - Segments Offering Most New Opportunities
33.3 Beovu Market In 2029 - Growth Strategies
33.3.1 Market Trend Based Strategies
33.3.2 Competitor Strategies
34. Appendix
34.1. Abbreviations
34.2. Currencies
34.3. Historic And Forecast Inflation Rates
34.4. Research Inquiries
34.5. About the Analyst
34.6. Copyright And Disclaimer

Executive Summary

Beovu Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on beovu market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for beovu ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The beovu market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Type: Macular Degeneration; Diabetic Retinopathy; Other Types
2) By Dosage Form: Gels; Eye Solutions; Capsules And Tablets; Eye Drops; Ointments
3) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
4) By End User: Adult; Geriatric

Key Companies Profiled: Novartis AG

Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Companies Mentioned

  • Novartis AG